Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002090209-25-000004
Filing Date
2025-10-06
Accepted
2025-10-06 17:14:23
Documents
2
Period of Report
2025-10-01

Document Format Files

Seq Description Document Type Size
1 form3-10062025_091019.html 3  
1 form3-10062025_091019.xml 3 10252
2 ex24-10062025_091019.htm EX-24 9031
  Complete submission text file 0002090209-25-000004.txt   20925
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Issuer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address
Caudill Cortney (Reporting) CIK: 0002090209 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32335 | Film No.: 251377617